The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
16.76
-0.72 (-4.12%)
Feb 21, 2025, 4:00 PM EST - Market closed
The Chemours Company Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 5,782 | 6,078 | 6,831 | 6,345 | 4,969 | Upgrade
|
| Revenue Growth (YoY) | -4.87% | -11.02% | 7.66% | 27.69% | -10.08% | Upgrade
|
| Cost of Revenue | 4,631 | 4,772 | 5,215 | 4,964 | 3,902 | Upgrade
|
| Gross Profit | 1,151 | 1,306 | 1,616 | 1,381 | 1,067 | Upgrade
|
| Selling, General & Admin | 602 | 526 | 705 | 583 | 526 | Upgrade
|
| Research & Development | 109 | 108 | 118 | 107 | 93 | Upgrade
|
| Other Operating Expenses | - | - | - | - | 1 | Upgrade
|
| Operating Expenses | 711 | 634 | 823 | 690 | 620 | Upgrade
|
| Operating Income | 440 | 672 | 793 | 691 | 447 | Upgrade
|
| Interest Expense | -264 | -208 | -163 | -185 | -210 | Upgrade
|
| Earnings From Equity Investments | 43 | 45 | 55 | 43 | 23 | Upgrade
|
| Currency Exchange Gain (Loss) | -9 | -38 | -15 | 3 | -26 | Upgrade
|
| Other Non Operating Income (Expenses) | 14 | 23 | 57 | 36 | 38 | Upgrade
|
| EBT Excluding Unusual Items | 224 | 494 | 727 | 588 | 272 | Upgrade
|
| Merger & Restructuring Charges | -60 | -153 | -16 | -6 | -32 | Upgrade
|
| Impairment of Goodwill | -56 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 106 | 23 | 115 | 8 | Upgrade
|
| Asset Writedown | - | - | - | - | -10 | Upgrade
|
| Legal Settlements | - | -764 | - | - | -37 | Upgrade
|
| Other Unusual Items | -1 | -1 | 7 | -21 | -22 | Upgrade
|
| Pretax Income | 127 | -318 | 741 | 676 | 179 | Upgrade
|
| Income Tax Expense | 41 | -81 | 163 | 68 | -40 | Upgrade
|
| Earnings From Continuing Operations | 86 | -237 | 578 | 608 | 219 | Upgrade
|
| Minority Interest in Earnings | - | -1 | - | - | - | Upgrade
|
| Net Income | 86 | -238 | 578 | 608 | 219 | Upgrade
|
| Net Income to Common | 86 | -238 | 578 | 608 | 219 | Upgrade
|
| Net Income Growth | - | - | -4.93% | 177.63% | - | Upgrade
|
| Shares Outstanding (Basic) | 149 | 149 | 155 | 165 | 165 | Upgrade
|
| Shares Outstanding (Diluted) | 150 | 149 | 158 | 169 | 166 | Upgrade
|
| Shares Change (YoY) | 0.85% | -5.93% | -6.16% | 1.41% | 0.93% | Upgrade
|
| EPS (Basic) | 0.58 | -1.60 | 3.72 | 3.69 | 1.33 | Upgrade
|
| EPS (Diluted) | 0.57 | -1.60 | 3.65 | 3.60 | 1.32 | Upgrade
|
| EPS Growth | - | - | 1.39% | 172.73% | - | Upgrade
|
| Free Cash Flow | -993 | 186 | 448 | 537 | 540 | Upgrade
|
| Free Cash Flow Per Share | -6.61 | 1.25 | 2.83 | 3.18 | 3.25 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Upgrade
|
| Gross Margin | 19.91% | 21.49% | 23.66% | 21.77% | 21.47% | Upgrade
|
| Operating Margin | 7.61% | 11.06% | 11.61% | 10.89% | 9.00% | Upgrade
|
| Profit Margin | 1.49% | -3.92% | 8.46% | 9.58% | 4.41% | Upgrade
|
| Free Cash Flow Margin | -17.17% | 3.06% | 6.56% | 8.46% | 10.87% | Upgrade
|
| EBITDA | 741 | 979 | 1,084 | 1,008 | 767 | Upgrade
|
| EBITDA Margin | 12.82% | 16.11% | 15.87% | 15.89% | 15.44% | Upgrade
|
| D&A For EBITDA | 301 | 307 | 291 | 317 | 320 | Upgrade
|
| EBIT | 440 | 672 | 793 | 691 | 447 | Upgrade
|
| EBIT Margin | 7.61% | 11.06% | 11.61% | 10.89% | 9.00% | Upgrade
|
| Effective Tax Rate | 32.28% | - | 22.00% | 10.06% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.